Nystatin Stada

Nystatin, the active ingredient in Nystatin Stada, is a polyol polyfungi presented as a dosage form for topical use. It treats superficial fungal infections such as candidiasis in infants, children and adults.

GNH USA supplies Nystatin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nystatin Stada is employed across several fungal‑related conditions, acting on Candida species that colonise mucosal surfaces and skin. - Oral thrush: Reduces fungal load and alleviates discomfort in the mouth and throat. - Esophageal candidiasis: Helps clear the infection of the esophagus. - Cutaneous candidiasis: Treats skin infections caused by Candida species. - Vaginal candidiasis: Relieves itching and discharge associated with yeast infections.

Nystatin may generate local or systemic reactions, most of which are mild and reversible.

Common Side Effects: - Mild skin irritation - Burning sensation - Itching of the application site - Red reddening of the skin - Nausea if swallowed - Taste alteration

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis or angio‑ang t ) . - Wound or ulcer formation at the application site . - Persistent diarr . - Hepat ").

Before ");

");"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""

""""  """

"" """"""""""""""""""""" 

""  g.